Artigo Acesso aberto Revisado por pares

15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Gastric Cancer

2009; American Association for Cancer Research; Volume: 15; Issue: 14 Linguagem: Inglês

10.1158/1078-0432.ccr-08-2518

ISSN

1557-3265

Autores

Alexandra Thiel, Aparna Ganesan, Johanna Mrena, Siina Junnila, Antti I. Nykänen, Annabrita Hemmes, Hsin‐Hsiung Tai, Outi Monni, Arto Kokkola, Caj Haglund, Tatiana V. Petrova, Ari Ristimäki,

Tópico(s)

Helicobacter pylori-related gastroenterology studies

Resumo

We have investigated the expression and regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in gastric cancer.Clinical gastric adenocarcinoma samples were analyzed by immunohistochemistry and quantitative real-time PCR for protein and mRNA expression of 15-PGDH and for methylation status of 15-PGDH promoter. The effects of interleukin-1beta (IL-1beta) and epigenetic mechanisms on 15-PGDH regulation were assessed in gastric cancer cell lines.In a gastric cancer cell line with a very low 15-PGDH expression (TMK-1), the 15-PGDH promoter was methylated and treatment with a demethylating agent 5-aza-2'-deoxycytidine restored 15-PGDH expression. In a cell line with a relatively high basal level of 15-PGDH (MKN-28), IL-1beta repressed expression of 15-PGDH mRNA and protein. This effect of IL-1beta was at least in part attributed to inhibition of 15-PGDH promoter activity. SiRNA-mediated knockdown of 15-PGDH resulted in strong increase of prostaglandin E(2) production in MKN-28 cells and increased cell growth of these cells by 31% in anchorage-independent conditions. In clinical gastric adenocarcinoma specimens, 15-PGDH mRNA levels were 5-fold lower in gastric cancer samples when compared with paired nonneoplastic tissues (n = 26) and 15-PGDH protein was lost in 65% of gastric adenocarcinomas (n = 210).15-PGDH is down-regulated in gastric cancer, which could potentially lead to accelerated tumor progression. Importantly, our data indicate that a proinflammatory cytokine linked to gastric carcinogenesis, IL-1beta, suppresses 15-PGDH expression at least partially by inhibiting promoter activity of the 15-PGDH gene.

Referência(s)